PeptiDream Inc. (4587) Other
Market cap
¥157.4B
P/E ratio
Peptidream develops new drugs using its proprietary PDPS platform and creates radiopharmaceuticals for diagnosing and treating cancer and other diseases.
| 2011/06 | 2012/06 | 2013/06 | 2014/06 | 2015/06 | 2016/06 | 2017/06 | 2018/06 | 2019/06 | 2019/12 | 2020/12 | 2021/12 | 2022/12 | 2023/12 | 2024/12 | 2025/12 | |
| Return on Assets | - | - | - | - | 14.6 | 16.1 | 14.8 | 21 | 15.2 | -2.8 | 19.3 | 13.6 | 17 | 4.6 | 18.5 | -0.6 |
| Return on equity (%) | - | - | - | |||||||||||||
| Employees | 11 | 25 | 25 | 28 | 43 | 47 | 60 | 83 | 104 | 107 | 128 | 141 | 569 | 603 | 621 | 645 |